Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101).
<p>Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101).</p>
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1852018937506562048 |
|---|---|
| author | Carlos Miguel Sirvent-Ruiz (21615546) |
| author2 | María Miranda (685792) María de la Villa Moral-Jiménez (21615549) |
| author2_role | author author |
| author_facet | Carlos Miguel Sirvent-Ruiz (21615546) María Miranda (685792) María de la Villa Moral-Jiménez (21615549) |
| author_role | author |
| dc.creator.none.fl_str_mv | Carlos Miguel Sirvent-Ruiz (21615546) María Miranda (685792) María de la Villa Moral-Jiménez (21615549) |
| dc.date.none.fl_str_mv | 2025-06-27T17:26:38Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0326853.t005 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Tests_of_Measurement_Invariance_of_the_PDAT-13_between_Participants_who_Completed_the_PDAT_within_30_Days_of_Admission_n_142_and_Participants_who_Completed_the_PDAT_after_30_Days_of_Treatment_n_101_/29426283 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Medicine Pharmacology Biotechnology Developmental Biology Infectious Diseases Plant Biology targeting interventions based proven clinical efficacy main instruments used 243 addicted subjects substance addiction environment xlink "> withdrawal item pdat questionnaire predictive validity 7 scale </ p xlink "> predictive validity addiction treatment discriminant validity sample consisted residential treatment predict contingency pdat consists new tool internal elements initial 26 general scale frequently lead factor structure factor analysis depressive anticipation current treatment actively engage 95 ), 63 years 15 days |
| dc.title.none.fl_str_mv | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101).</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_412f1eb69a286ff44beafc1915affdf2 |
| identifier_str_mv | 10.1371/journal.pone.0326853.t005 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/29426283 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101).Carlos Miguel Sirvent-Ruiz (21615546)María Miranda (685792)María de la Villa Moral-Jiménez (21615549)MedicinePharmacologyBiotechnologyDevelopmental BiologyInfectious DiseasesPlant Biologytargeting interventions basedproven clinical efficacymain instruments used243 addicted subjectssubstance addiction environmentxlink "> withdrawalitem pdat questionnairepredictive validity 7scale </ pxlink ">predictive validityaddiction treatmentdiscriminant validitysample consistedresidential treatmentpredict contingencypdat consistsnew toolinternal elementsinitial 26general scalefrequently leadfactor structurefactor analysisdepressive anticipationcurrent treatmentactively engage95 ),63 years15 days<p>Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101).</p>2025-06-27T17:26:38ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0326853.t005https://figshare.com/articles/dataset/Tests_of_Measurement_Invariance_of_the_PDAT-13_between_Participants_who_Completed_the_PDAT_within_30_Days_of_Admission_n_142_and_Participants_who_Completed_the_PDAT_after_30_Days_of_Treatment_n_101_/29426283CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/294262832025-06-27T17:26:38Z |
| spellingShingle | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). Carlos Miguel Sirvent-Ruiz (21615546) Medicine Pharmacology Biotechnology Developmental Biology Infectious Diseases Plant Biology targeting interventions based proven clinical efficacy main instruments used 243 addicted subjects substance addiction environment xlink "> withdrawal item pdat questionnaire predictive validity 7 scale </ p xlink "> predictive validity addiction treatment discriminant validity sample consisted residential treatment predict contingency pdat consists new tool internal elements initial 26 general scale frequently lead factor structure factor analysis depressive anticipation current treatment actively engage 95 ), 63 years 15 days |
| status_str | publishedVersion |
| title | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). |
| title_full | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). |
| title_fullStr | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). |
| title_full_unstemmed | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). |
| title_short | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). |
| title_sort | Tests of Measurement Invariance of the PDAT-13 between Participants who Completed the PDAT within 30 Days of Admission (n = 142) and Participants who Completed the PDAT after 30 Days of Treatment (n = 101). |
| topic | Medicine Pharmacology Biotechnology Developmental Biology Infectious Diseases Plant Biology targeting interventions based proven clinical efficacy main instruments used 243 addicted subjects substance addiction environment xlink "> withdrawal item pdat questionnaire predictive validity 7 scale </ p xlink "> predictive validity addiction treatment discriminant validity sample consisted residential treatment predict contingency pdat consists new tool internal elements initial 26 general scale frequently lead factor structure factor analysis depressive anticipation current treatment actively engage 95 ), 63 years 15 days |